Oscillatory Patterns of Gene Expression in Aging and Alzheimer’s Disease (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications that seek to enhance existing transcriptome and proteome data sets by revealing oscillatory patterns of gene expression in aging and in Alzheimer's disease (AD), by uncovering their molecular significance, and by identifying rhythmic gene and/or protein profiles associated with the risk for AD. Outcomes of this research may suggest novel opportunities for translational research to allow development of individualized, optimized treatment based on circadian phase and amplitude.


  • Letter of Intent Due Date(s): September 23, 2019
  • Application Due Date(s): October 23, 2019

RFA-AG-20-040 Expiration Date October 24, 2019

Agency Website



Amount Description

Applications may request no more than $600,000 in direct costs in any one year.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Funding Type





Medical - Basic Science
Medical - Translational

External Deadline

October 23, 2019